1/T2 and magnetic susceptibility measurements in a gerbil cardiac iron overload model

Radiology

Volumn 234, Issue 3, 2005, Pages 749-755

  Wang, Zhiyue J ^a,b   Lian, Lurong ^a   Chen, Qiukan ^a   Zhao, Huaqing ^a   Asakura, Toshio ^a   Cohen, Alan R ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IRON DEXTRAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GERBIL; HEART; IRON OVERLOAD; LINEAR REGRESSION ANALYSIS; MAGNETISM; MULTIPLE REGRESSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELAXATION TIME;

ANIMALS; DISEASE MODELS, ANIMAL; GERBILLINAE; IRON; IRON OVERLOAD; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MYOCARDIUM;

EID: 13844256816     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiol.2343031084     Document Type: Article

References (26)

1. Engle MA, Erlandson M, Smith CH. Late cardiac complications of chronic, severe, refractory anemia with hemochromatosis. Circulation 1964; 30:698-705.
2. Buja LM, Roberts WC. Iron in the heart etiology and clinical significance. Am J Med 1971; 51:209-221.
3. Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood 1997; 89:739-761.
4. Angelucci E, Brittenham GM, McLaren CE, et al. Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med 2000; 343:327-331.
5. Brittenham GM, Farrell DE, Harris JW, et al. Magnetic-susceptibility measurement of human iron stores. N Engl J Med 1982; 307:1671-1675.
6. Sanyal SK, Johnson W, Jayalakshmamma B, Green AA. Fatal "iron heart" in an adolescent: biochemical and ultrastructural aspects of the heart. Pediatrics 1975; 55:336-341.
7. Fitchett DH, Coltart DJ, Littler WA, et al. Cardiac involvement in secondary haemochromatosis: a catheter biopsy study and analysis of myocardium. Cardiovasc Res 1980; 14:719-724.
8. Brittenham GM, Badman DG. Noninvasive measurement of iron: report of an NIDDK workshop. Blood 2003; 101:15-19.
9. Mavrogeni SI, Gotsis ED, Markussis V, et al. T2 relaxation time study of iron overload in b-thalassemia. MAGMA 1998; 6:7-12.
10. Papanikolaou N, Ghiatas A, Kattamis A, Ladis C, Kritikos N, Kattamis C. Non-invasive myocardial iron assessment in thalassaemic patients: T2 relaxometry and magnetization transfer ratio measurements. Acta Radiol 2000; 41:348-351.
11. Jensen PD, Jensen FT, Christensen T, Heickendorff L, Jensen LG, Ellegaard J. Indirect evidence for the potential ability of magnetic resonance imaging to evaluate the myocardial iron content in patients with transfusional iron overload. MAGMA 2001; 12:153-166.
12. Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 2001; 22:2171-2179.
13. Jensen PD, Jensen FT, Christensen T, Eiskjaer H, Baandrup U, Nielsen JL. Evaluation of myocardial iron by magnetic resonance imaging during iron chelation therapy with deferrioxamine: indication of close relation between myocardial iron content and chelatable iron pool. Blood 2003; 101:4632-4639.
14. Liu P, Henkelman M, Joshi J, et al. Quantification of cardiac and tissue iron by nuclear magnetic resonance relaxometty in a novel murine thalassemia-cardiac iron overload model. Can J Cardiol 1996; 12:155-164.
15. Carthew P, Dorman BM, Edwards RE, Francis JE, Smith AG. A unique rodent model for both the cardiotoxic and hepatotoxic effects of prolonged iron overload. Lab Invest 1993; 69:217-222.
16. Hershko C, Link G, Konijn AM, Huerta M, Rosenmann E, Reinus C. The iron-loaded gerbil model revisited: effects of deferoxamine and deferiprone treatment. J Lab Clin Med 2002; 139:50-58.
17. Kuryshev YA, Brittenham GM, Fujioka H, et al. Decreased sodium and increased transient outward potassium currents in iron-loaded cardiac myocytes: implications for the arrhythmogenesis of human siderotic heart disease. Circulation 1999; 100:675-683.
18. Thickman DI, Kundel HL, Wolf G. Nuclear magnetic resonance characteristics of fresh and fixed tissue: the effect of elapsed time. Radiology 1983; 148:183-185.
19. Wang ZJ, Li S, Haselgrove JC. Magnetic resonance imaging measurement of volume magnetic susceptibility using a boundary condition. J Magn Reson 1999; 140:477-481.
20. Johnston DL, Rice L, Vick GW 3rd, Hedrick TD, Rokey R. Assessment of tissue iron overload by nuclear magnetic resonance imaging. Am J Med 1989; 87:40-47.
21. Schwartz KA, Fisher J, Adams ET. Morphologic investigations of the guinea pig model of iron overload. Toxicol Pathol 1993; 21:311-320.
22. Liu P, Johnston DL, Brady TJ, Lutrario DM, Okada RD. The alterations of magnetic resonance relaxation parameters in excised myocardial tissue during NMR spectroscopy: the effects of time, environmental exposure and TTC staining. Magn Reson imaging 1989; 7:109-113.
23. Brittenham GM, Sheth S, Allen CJ, Farrell DE. Noninvasive methods for quantitative assessment of transfusional iron overload in sickle cell disease. Semin Hematol 2001; 38(suppl 1):37-56.
24. Bauman JH, Harris JW. Estimation of hepatic iron stores by in vivo measurement of magnetic susceptibility. J Lab Clin Med 1967; 70:246-257.
25. Rahko PS, Salerni R, Utetsky BF. Successful reversal by chelation therapy of congestive cardiomyopathy due to iron overload. J Am Coll Cardiol 1986; 8:436-440.
26. Wacker P, Halperin DS, Balmer-Ruedin D, Oberhansli I, Wyss M. Regression of cardiac insufficiency after ambulatory intravenous deferoxamine in thalassemia major. Chest 1993; 103:1276-1278.